• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Idera Pharmaceuticals Inc

+ Add to Watchlist

HXXA:GR

3.275 EUR 0.022 0.68%

As of 13:45:30 ET on 12/19/2014.

Snapshot for Idera Pharmaceuticals Inc (HXXA)

Open: 3.313 Day's Range: 3.228 - 3.447 Volume: 350
Previous Close: 3.253 52wk Range: 1.482 - 5.000 1-Yr Rtn: +35.33%

Stock Chart for HXXA

No chart data available.
  • HXXA:GR 3.275
  • 1D
  • 1M
  • 1Y
3.253
Interactive HXXA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HXXA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.4500
Est. PEG Ratio -
Market Cap (M EUR) 281.03
Shares Outstanding (M) 85.81
30 Day Average Volume 697
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HXXA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HXXA

Idera Pharmaceuticals, Inc. is a biotechnology company. The Company develops therapeutics that modulate the immune response through Toll-like receptors. Idera is working on therapeutics for oncology, asthma/allergy, and infectious diseases.

Vincent J Milano "Vin"President/CEOSudhir D Agrawal "Phil"President:Research
Louis J Arcudi IIISenior VP/CFO/Treasurer/SecyLouis BrennerSenior VP/Chief Medical Ofcr
More Company Profile & Key Executives for HXXA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil